Molecular evolutionary studies of Lassa virus nucleoprotein 2

Asian Pacific Journal of Tropical Disease

Volumn 1, Issue 1, 2011, Pages 28-34

  Okoror, L E ^a   Eniolorunda, T A ^a   Okoror, O I ^b  

^a JOSEPH AYOBABALOLA UNIVERSITY   (Nigeria)

^b AMBROSE ALLI UNIVERSITY   (Nigeria)

Author keywords

Arena viruses; Circulating antibodies; Lassa fever; Lassa virus; MEGA; Molecular evolutionary; Nucleoprotein; Nucleotide sequence; Phylogenetic tree; Synonymous substitution; Viral glycoprotein; Virulence diversity

Indexed keywords

LASSA VIRUS NUCLEOPROTEIN 2; NUCLEOTIDE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS NUCLEOPROTEIN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; INFORMATION PROCESSING; LASSA VIRUS; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPECIES DIFFERENCE; VIRUS ISOLATION; VIRUS STRAIN;

EID: 79960254132     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(11)60007-8     Document Type: Article

References (30)

1. Schlie K, Maisa A, Lennartz A, Ströher U, Garten W, Strecker T Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication. J Virol 2010, 84(2):983-992.
2. Schlie K, Maisa A, Lennartz F, Strecker T Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants. PLoS Negl Trop Dis 2009, 4(2):923-933.
3. Kerneis S, Koivogui L, Magassouba N, Koulemu K, Lewis R, Aplogan A, et al. Prevalence and risk factors of Lassa virus seropositivity in inhabitants of the forest region of Guinea: a cross sectional study. PLOs Negl Dis 2009, 3(11):e548.
4. Branco LM, Grove JN, Geske FJ, Boisen ML, Muncyn IJ, Magliato SA, et al. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for lassa heamorrhagic fever. Virol J 2010, 7:296.
5. Geisbert TW, Jones S, Fritz EA, Shurtleff AC, Geisbert JB, Leibscher R, et al. Development of a new vaccine for the prevention of Lassa fever. PLOs Med 2005, 2(6):e183.
6. Fichet-Calvet E, Rogers DJ Risk maps of Lassa fever in West Africa. PLoS Negl Trop Dis 2009, 3(3):e388.
7. Bredenbeek PJ, Molenkamp R, Spaan WJM, Deubel V, Marianneau P, Salvato MS, et al. A recombinant yellow fever 17D vaccine expressing lassa virus glycoprotein. Virol 2006, 345(2):299-304.
8. Carrion R, Patterson JL, Johnson C, Gonzales M, Moreira CR, Ticer A, et al. A ML29 reassortant virus protects guinea pigs against a distantly-related Nigeria strain of lassa virus and can provide sterilizing immunity. Vaccine 2007, 25(20):4093-4102.
9. Flatz L, Rieger T, Merkler D, Bergthaler A, Regen T, Schedensack M, et al. T-dependent lassa fever pathogenesis. PLoS Patho 2010, 6(3):e1000836.
10. Gallaher WR, DiSimone C, Buchmeier MJ The viral transmembrane superfamily: Possible divergence of arenavirus and filovirus glycoproteins from a common RNA virus ancestor. BMC Microbiol 2001, 38:2670-2677.
11. Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, et al. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescentantibody test, and virus isolation. J Clin Microbiol 2000, 21:234-239.
12. Okoror LE, Alaiya HT, Imarenezor KP, Aliga P, Erimafa JT Molecular evolution of Lassa virus glycoprotein. Schriftenreihe Informatik 2007, 26:21-29.
13. Omilabu SA, Badaru SO, Okokhere P, Asogun D, Drosten C, Emmerich P, et al. Lassa fever, Nigeria, 2003 and 2004. Emerg Infect Dis 2005, 11(10):1642-1644.
14. Botten J, Alexander J, Pasquetto V, Sidney J, Barrowman P, Ting J, et al. Identification of protective Lassa virus epitopes that are restricted to by HLA-A2. J Virol 2006, 80(17):8351-8361.
15. Takeda N, Tanimura M, Tiyamura K Molecular evolution of major capsid protein VP1 of enterovirus 70. J Virol 1994, 844-862.
16. Tamura K, Nei M, Kumar S Prospects for inferring very large phylogenies by using the neighbor-joining method. PNAS 2004, 101:11030-11035.
17. Tamura K, Dudley J, Nei M, Kumar S MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Molecular Biol Evolution 2007, 10.1093/molbev/msm092.
18. Li WH, Wu CI, Luo CC A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes. Mol Biol Evol 1985, 2:150-174.
19. Miyamura KM, Tanimura N, Kono TR, Yamazaki S Evolution of enterovirus 70 in nature: all isolates were recently derived from a common ancestor. Arch Virol 1986, 89:1-14.
20. Banseh DG, Rollin PE, Demby AH, Coulibally M, Karu J, Conteh AS Diagnosis and clinical virology of lassa fever as evaluated by enzyme-linked immunosorbent assay. Indirect fluorescence antibody test and virus isolation. Clin Microbial 2000, 38:2670-2677.
21. Gorman OT, Bean WJ, Kawaoka Y, Webster RG Evolution of the nucleoprotein gene of influenza A virus. J Virol 1990, 64:1487-1497.
22. Shu LL, Bean WJ, Webster RG Analysis of the evolution and variation of the human influenza A virus nucleoprotein gene from 1933 to 1990. J Virol 1993, 67:2723-2729.
23. Gorman OT, Donis RO, Kawaoka Y, Webster RG Evolution of influenza A virus PB2 genes: implications for evolution of the ribonucleoprotein complex and origin of human influenza A virus. J Virol 1990, 64:4893-4902.
24. Kamagae Y, Sugita S, Endo A, Ishida M, Senya S, Osako K, et al. Evolutionary pattern of the hemoglutinin gene of influenza B viruses isolated in Japan: co-circulating lineages in the same epidemic season. J Virol 1990, 64(6):2860-2865.
25. Yamashita M, Krystal M, Fitch WM, Palese P Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses. Virology 1998, 163:112-122.
26. Gojobori T, Li WH, Graur D Patterns of nucleotide substitution in pseudogenes and functional genes. J Mol Evol 1982, 18:360-369.
27. Saitou N Patterns of nucleotide substitutions in influenza A virus genes. Jpn J Genet 1987, 62:439-443.
28. Ghafoor A, Burney ML, Iqbal J, Khan Z Acute haemorrhagic conjunctivitis (AHC) epidemic of 1981. J Pak Med Assoc 1984, 34:245-246.
29. Hass M, Westerkofsky M, Müller S, Becker-Ziaja B, Busch C, Günther S Mutational analysis of lassa virus promoter. J Virol 2006, 80(24):12414-12419.
30. Cosset F, Marianneau P, Verney G, Gallais F, Tordo N, Percheur E, et al. Characterization of Lassa virus cell entry and neutralization with lassa virus pseudoparticles. J Virol 2009, 3228-3237.